JP2019523226A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523226A5 JP2019523226A5 JP2018564844A JP2018564844A JP2019523226A5 JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5 JP 2018564844 A JP2018564844 A JP 2018564844A JP 2018564844 A JP2018564844 A JP 2018564844A JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5
- Authority
- JP
- Japan
- Prior art keywords
- sbt
- oil
- pufa
- pharmaceutical composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346755P | 2016-06-07 | 2016-06-07 | |
| US62/346,755 | 2016-06-07 | ||
| PCT/US2017/036330 WO2017214260A1 (en) | 2016-06-07 | 2017-06-07 | Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019523226A JP2019523226A (ja) | 2019-08-22 |
| JP2019523226A5 true JP2019523226A5 (https=) | 2020-07-27 |
| JP7518604B2 JP7518604B2 (ja) | 2024-07-18 |
Family
ID=60578981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018564844A Active JP7518604B2 (ja) | 2016-06-07 | 2017-06-07 | タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10206875B2 (https=) |
| EP (1) | EP3463299A4 (https=) |
| JP (1) | JP7518604B2 (https=) |
| CN (2) | CN116019768A (https=) |
| AU (1) | AU2017277497B2 (https=) |
| CA (1) | CA3026412A1 (https=) |
| IL (1) | IL263504A (https=) |
| MX (1) | MX2018015112A (https=) |
| WO (1) | WO2017214260A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7518604B2 (ja) * | 2016-06-07 | 2024-07-18 | タルガジェニックス，インコーポレイテッド | タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 |
| JP7450888B2 (ja) * | 2017-12-20 | 2024-03-18 | タルガジェニックス，インコーポレイテッド | がんにおける免疫療法との併用タキソイドナノエマルジョン |
| US20220226480A1 (en) * | 2019-03-22 | 2022-07-21 | Integrated Nanotherapeutics Inc. | Lipid conjugate prepared from scaffold moiety |
| KR20220099585A (ko) * | 2019-10-25 | 2022-07-13 | 암젠 인크 | 낮은 단백질 농도에서 단백질 손실을 최소화하기 위한 조성물 및 방법 |
| JP2023500365A (ja) * | 2019-11-05 | 2023-01-05 | ルミナス バイオサイエンシズ，インク． | がんおよび他の疾患の治療用のアルブミンで安定化されたプロドラッグを含むナノ粒子 |
| CN111004195B (zh) * | 2019-12-03 | 2022-01-28 | 沈阳药科大学 | 卡巴他赛弱碱性衍生物及其制剂 |
| CN114317398B (zh) * | 2020-09-27 | 2024-03-01 | 中国科学院分子细胞科学卓越创新中心 | Gli1和EpCAM基因共同标记的肝祖细胞群及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426367B1 (en) * | 1999-09-09 | 2002-07-30 | Efa Sciences Llc | Methods for selectively occluding blood supplies to neoplasias |
| WO2005041881A2 (en) * | 2003-10-30 | 2005-05-12 | The Research Foundation Of State University Of New York | Taxoid-fatty acid conjugates and pharmaceutical compositions thereof |
| US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
| US20070148194A1 (en) | 2005-11-29 | 2007-06-28 | Amiji Mansoor M | Novel nanoemulsion formulations |
| CA2731353A1 (en) * | 2008-07-23 | 2010-02-18 | Bharat Serums & Vaccines Ltd. | Stable injectable oil-in-water docetaxel nanoemulsion |
| US20100021471A1 (en) * | 2008-07-25 | 2010-01-28 | Brookhaven Science Associates, Llc | Carbon nanotube-based drug delivery systems and methods of making same |
| US20140105829A1 (en) * | 2012-10-15 | 2014-04-17 | Nemucore Medical Innovations, Inc. | Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same |
| ES2851332T3 (es) * | 2014-06-19 | 2021-09-06 | Solural Pharma ApS | Forma sólida de dosificación oral de compuestos lipofílicos |
| WO2015198350A1 (en) * | 2014-06-25 | 2015-12-30 | Synergia Bio Sciences Private Limited | A pharmaceutical oil-in-water nano-emulsion |
| JP7518604B2 (ja) * | 2016-06-07 | 2024-07-18 | タルガジェニックス，インコーポレイテッド | タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 |
| JP7450888B2 (ja) * | 2017-12-20 | 2024-03-18 | タルガジェニックス，インコーポレイテッド | がんにおける免疫療法との併用タキソイドナノエマルジョン |
-
2017
- 2017-06-07 JP JP2018564844A patent/JP7518604B2/ja active Active
- 2017-06-07 WO PCT/US2017/036330 patent/WO2017214260A1/en not_active Ceased
- 2017-06-07 CN CN202310169465.9A patent/CN116019768A/zh active Pending
- 2017-06-07 AU AU2017277497A patent/AU2017277497B2/en active Active
- 2017-06-07 CA CA3026412A patent/CA3026412A1/en active Pending
- 2017-06-07 MX MX2018015112A patent/MX2018015112A/es unknown
- 2017-06-07 US US15/616,103 patent/US10206875B2/en not_active Ceased
- 2017-06-07 EP EP17810927.8A patent/EP3463299A4/en active Pending
- 2017-06-07 CN CN201780047015.5A patent/CN109562065A/zh active Pending
-
2018
- 2018-12-04 IL IL263504A patent/IL263504A/en unknown
-
2021
- 2021-02-19 US US17/179,720 patent/USRE50096E1/en active Active
-
2024
- 2024-07-16 US US18/774,363 patent/US20250009658A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523226A5 (https=) | ||
| Panzarini et al. | Novel therapeutic delivery of nanocurcumin in central nervous system related disorders | |
| Delshadi et al. | Micro and nano-encapsulation of vegetable and essential oils to develop functional food products with improved nutritional profiles | |
| Assadpour et al. | Cannabidiol-loaded nanocarriers and their therapeutic applications | |
| Leyva-Gómez et al. | Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art | |
| Obeid et al. | Delivering natural products and biotherapeutics to improve drug efficacy | |
| Liu et al. | Salidroside promotes peripheral nerve regeneration based on tissue engineering strategy using Schwann cells and PLGA: in vitro and in vivo | |
| Sonu Ambwani et al. | Current knowledge on nanodelivery systems and their beneficial applications in enhancing the efficacy of herbal drugs. | |
| AU2015211711B2 (en) | Orally administered agent for ruminants and ruminant feed containing same | |
| Eskandani et al. | Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles | |
| Blanco-Llamero et al. | Nutraceuticals and food-grade lipid nanoparticles: from natural sources to a circular bioeconomy approach | |
| US20250009658A1 (en) | Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells | |
| Kundu et al. | Prospect of natural products in glioma: a novel avenue in glioma management | |
| Liu et al. | Advances in transdermal drug delivery systems and clinical applications in inflammatory skin diseases | |
| Ratan et al. | Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer | |
| Jahangir et al. | Transdermal nutraceuticals delivery system for CNS disease | |
| Shen et al. | Advancements in Antioxidant-Based therapeutics for spinal cord injury: A critical review of strategies and combination approaches | |
| Bhushani et al. | Nanodelivery of nutrients for improved bioavailability | |
| ES2992095T3 (es) | Monoglicéridos de ácidos grasos poliinsaturados, composiciones y uso de los mismos para modular la composición de la microbiota de un sujeto | |
| JP2021517906A5 (https=) | ||
| Zhu et al. | Advances in conventional and innovative anti-allergic agents for managing food allergies: from mechanisms to challenges | |
| Karroum et al. | Efficacy and safety of sulforaphane-loaded emulsomes as tested on MCF7 and MCF10A cells | |
| Jiang et al. | Food-grade nanostructured delivery systems for oral administration of astaxanthin: Bioprocessing strategies and therapeutic applications | |
| Kim et al. | Nanoparticle encapsulation of the hexane fraction of Cyperus Rotundus extract for enhanced antioxidant and anti-Inflammatory activities in vitro | |
| Castro-Pastrana et al. | Recent advances on nanostructured materials for drug delivery and release |